New partnership with major European diagnostics group
Manchester, UK - 13 February 2017: Premaitha Health PLC (AIM: NIPT), developer of a leading CE-marked non-invasive prenatal screening system, announces a partnership with a major international diagnostics services group to implement the IONA® test in at least two laboratories.
Premaitha, through its distribution network, has secured a four-year Master Procurement Agreement (the… Read More
No surprise there then, still we can release our own version after doing our due diligence and freedom to operate, and then get our backsides sued......?
I'm sure Prem have implied in the past that they are investigating this Oncology and LB field and you could well argue that should case go our way then we may well be free to openly discuss application of current technology into new fields.
Page 18 of today's Times has an article on this research and LB
The group involved in the study use Illumina platforms for all their DNA sequencing. They are also involved in a consortium called GRAIL which uses Illumina tech. I think premaitha have missed the boat on this one.
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.